Bestrophin gene mutations in patients with best vitelliform macular dystrophy

Citation
Gm. Caldwell et al., Bestrophin gene mutations in patients with best vitelliform macular dystrophy, GENOMICS, 58(1), 1999, pp. 98-101
Citations number
17
Categorie Soggetti
Molecular Biology & Genetics
Journal title
GENOMICS
ISSN journal
08887543 → ACNP
Volume
58
Issue
1
Year of publication
1999
Pages
98 - 101
Database
ISI
SICI code
0888-7543(19990515)58:1<98:BGMIPW>2.0.ZU;2-B
Abstract
Best vitelliform macular dystrophy (VMD2) is an autosomal dominant dystroph y with a juvenile age of onset. Mutations in the Bestrophin gene were shown in patients affected with VMD2. In a mutation study, we made three new and interesting observations. First, we identified possible mutation hotspots within the gene, suggesting that particular regions of the protein have gre ater functional significance than others. Second, we described a 2-bp delet ion in a part of the gene where mutations have not previously been reported ; this mutation causes a frameshift and subsequent premature termination of the protein. Finally, we have evidence that some mutations are associated with variable expression of the disease, suggesting the involvement of othe r factors or genes in the disease phenotype. (C) 1999 Academic Press.